JAKARTA, WARTA-APOTEKER.com – ASEAN-Japan Pharmaceuticals Training in Risk Management Plan (RMP) 2023 is a collaboration program conducted by The Indonesian FDA, Pharmaceuticals and Medical Devices Agency (PMDA, Japan), and Universitas Indonesia (UI) with the support of the Japan-ASEAN Integration Fund (JAIF).
This project aims to advance regulatory harmonization activities concerning drug products among the ASEAN Member States. The program consists of a seminar geared toward four regulatory staff of each ASEAN Member State and a symposium for disseminating essential regulatory information to the industry and academia, and exchanging perspectives among regulators, industries and academia.
ASEAN-Japan Risk Management Plan (RMP) Symposium 2023
The Indonesian FDA, Pharmaceuticals and Medical Devices Agency (PMDA, Japan) and Universitas Indonesia (UI) collaborate to present you The ASEAN-Japan Risk Management Plan (RMP) Symposium 2023 on May 24th-26th 2023.
The seminar focus on sharing the latest information on RMP for regulatory authority officials. We welcome all regulatory authority officials engaged in pharmaceutical products review or pharmacovigilance activities in the ASEAN Member States (AMS). The Government of Japan supports the symposium through the Japan-ASEAN Integration Fund (JAIF).
